Confident Investing Starts With TipRanks Premium

Go Ultimate 55% OFF

ONC Stock Latest News

Company AnnouncementsBeOne Medicines’ Lung Cancer Combo Trial Nears Key Data Milestone1d agoONC

The FlyBeOne Medicines presents new data across solid tumor disease areas at ESMO 20266d agoONC
Company AnnouncementsBeOne Medicines Completes Key Sonrotoclax Formulation Study, Trimming Early-Stage Risk1w agoONC
The FlyBeOne Medicines reports ‘sustained survival benefit’ with TEVIMBRA-ZIIHERA combo1w agoONC
The FlyBeOne Medicines price target raised to $425 from $405 at Morgan Stanley2w agoONC

BeOne Medicines Advances BGB-43395 With New Drug Interaction Study Update

Company AnnouncementsBeOne Medicines Advances BGB-43395 With New Drug Interaction Study Update3w agoONC

The FlyBeOne Medicines price target raised to $459 from $450 at RBC Capital3w agoONC

The FlyBeOne Medicines price target raised to $420 from $418 at Truist3w agoONC

Company AnnouncementsBeOne Medicines Advances Tacabrutideg With New Liver Function Study4w agoONC
Company AnnouncementsBeOne Medicines Advances Sonrotoclax Safety Study in Patients With Severe Liver Impairment4w agoONC
The FlyBeOne Medicines price target raised to $445 from $425 at JPMorgan1M agoONC
Company AnnouncementsBeOne Medicines Advances BGB-58067 Tablet Study, Sharpening Early-Stage Investor Focus1M agoONC

BeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B2033

Company AnnouncementsBeOne Medicines Advances Phase 3 Liver Cancer Trial With BGB-B20331M agoONC

Company AnnouncementsSonrotoclax Safety Study Completion Signals Next Steps for BeOne Medicines1M agoONC

Company AnnouncementsBeOne Medicines Advances BG-85738 Into First-in-Human RAS Cancer Trial1M agoONC

The FlyBeOne Medicines price target raised to $415 from $407 at Barclays1M agoONC
The FlyBeOne Medicines to expand access to cancer medicines under pact with U.S.2M agoONC
The FlyBeOne Medicines announces new Phase 3 survival data on Ziihera2M agoONC
The FlyBeOne announces FDA approval for Tevimbra-based reginmen for HER2+ GEA2M agoONC JAZZ

Zymeworks says partner Jazz receives FDA approval for Ziihera regimens

The FlyZymeworks says partner Jazz receives FDA approval for Ziihera regimens2M agoONC JAZZ

Company AnnouncementsBeiGene Wraps Key Drug Interaction Study for BGB-16673, Sharpening Oncology Pipeline Outlook2M agoONC

Company AnnouncementsEarly-Stage HH160 Cancer Trial Puts BeOne Medicines on Long-Term Investors’ Radar2M agoONC